Skip to content

Clinical implications of DNA analysis on ADPKD

Clinical implications of DNA analysis on ADPKD - DNAPKD study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000018764
Enrollment
85
Registered
2015-08-22
Start date
2013-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autosomal Dominant Polycystic Kidney Disease

Interventions

None listed

Sponsors

ADPKD Research section, Kyorin University, School of Medicine
Lead Sponsor
Otsuka Pharmaceutical Co., Ltd.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Autosomal Dominant Polycystic Kidney Disease

Exclusion criteria

Exclusion criteria: The patients who do not consent.

Design outcomes

Primary

MeasureTime frame
The relationship between mutational type and phenotype.

Secondary

MeasureTime frame
The efficacy of next generation sequencing method

Countries

Japan

Contacts

Public ContactFumie Kobayashi

Research Promoting Center Kyorin University Research Promoting Center

kenkyushien@ks.kyorin-u.ac.jp0422-47-5511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026